Carregant...

IGHV Mutational Status Testing in Chronic Lymphocytic Leukemia

As the therapeutic landscape for chronic lymphocytic leukemia (CLL) continues to expand, biological predictors of response to therapy are becoming increasingly important. One such predictive biomarker is the mutational status of the variable region of the immunoglobulin heavy chain (IGHV) gene, whic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hematol
Autors principals: Crombie, Jennifer, Davids, Matthew S.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675754/
https://ncbi.nlm.nih.gov/pubmed/28589701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24808
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!